2.1. Study Design and Participants
This study was a randomized, double-blind, double-simulation, and positive drug control multicenter clinical trial (ClinicalTrials.gov registration number: Inclusion criteria are as follows: according to WHO criteria, age 18-70 years old, BMI between 21 and 35 kg/m